Jiangsu Hengrui Medicine Co., Ltd.
600276
Rank in Stocks
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Share Price
$6.89
Market Cap
$43.94B
Change (1 day)
-2.91%
Change (1 year)
-24.78%
Country
CN
Trade Jiangsu Hengrui Medicine Co., Ltd. (600276)
Category
Healthcare
Number of shares outstanding for Jiangsu Hengrui Medicine Co., Ltd. (600276)
Number of shares outstanding as of October 2026: 0
According to Jiangsu Hengrui Medicine Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Jiangsu Hengrui Medicine Co., Ltd. (600276) from 2001 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 6.50B | 2.58% |
| 2024 | 6.34B | 0.15% |
| 2023 | 6.33B | -0.63% |
| 2022 | 6.37B | -0.21% |
| 2021 | 6.38B | 0.38% |
| 2020 | 6.36B | 0.31% |
| 2019 | 6.34B | -0.42% |
| 2018 | 6.36B | 1.14% |
| 2017 | 6.29B | -0.45% |
| 2016 | 6.32B | -0.18% |
| 2015 | 6.33B | 0.46% |
| 2014 | 6.30B | -0.11% |
| 2013 | 6.31B | 0.29% |
| 2012 | 6.29B | -0.01% |
| 2011 | 6.29B | 0.36% |
| 2010 | 6.27B | 0.00% |
| 2009 | 6.27B | 0.26% |
| 2008 | 6.25B | -0.01% |
| 2007 | 6.25B | 0.00% |
| 2006 | 6.25B | 87.25% |
| 2005 | 3.34B | 0.00% |
| 2004 | 3.34B | 0.00% |
| 2003 | 3.34B | 0.00% |
| 2002 | 3.34B | 0.00% |
| 2001 | 3.34B | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
